All Blogs

Feb 11, 2021

Verily collaborates with Janssen to launch COVID-19 immune response study Verily is partnering with Johnson & Johnson’s Janssen division to witness the body’s earliest immune responses to a coronavirus infection, with people participating in the research from within their homes.  The study will be launche...

Jul 16, 2025

Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS) and Benjamin button disease, is one of the rarest and most dramatic genetic disorders known to medicine. Characterized by rapid and premature ageing in children, this condition affects approximately 1 in 20 million people worldwide. Children with p...

Feb 09, 2021

Deerfield and Dana-Farber Establish Links in USD 130 Million Cancer Research Deal  Deerfield Management has entered into a research agreement with Dana-Farber Cancer Institute to fuel the development of therapeutics and diagnostics for cancer. The move came not long after healthcare investor giant Deerfield...

Feb 08, 2021

Cystic Fibrosis is a rare inherited disorder that causes loss of lung function and damages the digestive system. It has a higher prevalence in the Caucasian population. For years there was no treatment available targeting the underlying cause, however, this changed in 2012 with the launch of Vertex Pharma’s Kalydec...

Feb 05, 2021

Smoking is the leading preventable cause of death in the world. However, prior to 1900, tobacco smoking was an uncommon sight. It was not until the 20th century that smoking cigarettes became a routine or more precisely a popular trend among youths and adults. What helped in booming its adoption were effective adve...

Feb 04, 2021

Plaque psoriasis drug outshines the competition in phase III trial Bristol Myers Squibb’s psoriasis drug, the TYK2 inhibitor outshone placebo and Amgen’s Otezla in a second phase 3 study, setting discussions with regulators. The study, known as POETYK PSO-2, trialled the drug, deucravacitinib, against placebo...

Feb 03, 2021

Information and Communications Technology (ICT) over the past few years have changed the way of communication. Among all the communication mediums, social media, in particular, has got a lot of attention and offers a huge benefit over traditional media. It has empowered the common man to quickly and easily get acce...

Feb 03, 2021

It is all about finding echoes of others within us! Holler folks! Welcome to Let's Hear It. Today, we bring you the second post of our series Let's Hear It. Earlier, we had a beautiful piece authored by our COO that highlighted the importance of Mental health. In this fast-paced life, we often forget or say negl...

Feb 02, 2021

Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio Buyout Horizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion to augment its portfolio and pipeline of treatments for rare diseases. The shares of Viela Bio skyrocketed more than 52% in premarket trading after the...

Feb 01, 2021

Cough! Cough! Every time something goes down the wrong pipe, we cough it out. Within seconds, it gets normal. We catch flu, or cold, cough accompanies for a week or two. However, what if cough decides to befriend the person for a time period more than usual, say, around eight weeks or more? It can be worrisome, and...